Elevated Reward Region Responsivity Predicts Future Substance Use Onset but Not Overweight/obesity Onset
Overview
Authors
Affiliations
Background: We tested the hypotheses that adolescents who show elevated reward region responsivity are at increased risk for initial onset of overweight/obesity and substance use, which is important because there have been no such prospective tests of the reward surfeit model of these motivated behaviors.
Methods: One hundred sixty-two adolescents (mean age = 15.3±1.06 years) with healthy weights (mean body mass index = 20.8±1.90) completed functional magnetic resonance imaging paradigms that assessed neural activation in response to receipt and anticipated receipt of palatable food and monetary reward; body fat and substance use were assessed at baseline and 1-year follow-up.
Results: Elevated caudate (r = .31, p<.001) and putamen (r = .28, p<.001) response to monetary reward predicted substance use onset over 1-year follow-up, but reward circuitry responsivity did not predict future overweight/obesity onset. Adolescents who reported substance use versus abstinence at baseline also showed less caudate (r =-.31, p<.001) response to monetary reward.
Discussion: Results show that hyper-responsivity of reward circuitry increases risk for future substance use onset, providing novel support for the reward surfeit model. Results also imply that even a limited substance use history was associated with reduced reward region responsivity, extending results from studies that compared substance-dependent individuals with healthy control subjects and suggesting that substance use downregulates reward circuitry. However, aberrant reward region responsivity did not predict initial unhealthy weight gain.
Methamphetamine alters nucleus accumbens neural activation to monetary loss in healthy young adults.
Crane N, Molla H, de Wit H Psychopharmacology (Berl). 2023; 240(9):1891-1900.
PMID: 37530883 PMC: 10572040. DOI: 10.1007/s00213-023-06398-4.
Affect-Related Brain Activity and Adolescent Substance Use: A Systematic Review.
Goncalves S, Ryan M, Niehaus C, Chaplin T Curr Behav Neurosci Rep. 2023; 9(1):11-26.
PMID: 37009067 PMC: 10062006. DOI: 10.1007/s40473-021-00241-w.
McQuaid G, Darcey V, Patterson A, Rose E, VanMeter A, Fishbein D Front Psychiatry. 2022; 13:1025259.
PMID: 36569626 PMC: 9780121. DOI: 10.3389/fpsyt.2022.1025259.
Jonker N, Timmerman M, de Jong P Front Psychol. 2022; 13:929255.
PMID: 36033026 PMC: 9404870. DOI: 10.3389/fpsyg.2022.929255.
Lindenmuth M, Herd T, Brieant A, Lee J, Deater-Deckard K, Bickel W Dev Cogn Neurosci. 2022; 55:101111.
PMID: 35472691 PMC: 9061620. DOI: 10.1016/j.dcn.2022.101111.